The British Society for Rheumatology has moved toward a life course approach when updating guidelines for several rheumatic ...

Endurance Techn, Solar Ind, GlaxoSmithKline, Gland, and Motilal Oswal marked their presence among the top gainers in the ...

Depemokimab reduces exacerbations regardless of baseline asthma control, suggesting uncontrolled symptoms are not necessary ...

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

Tezepelumab, a monoclonal antibody targeting thymic stromal lymphopoietin approved for add-on severe asthma treatment in 2021 ...

Peter Humphrey, a former journalist and private investigator, believes a Chinese surveillance team were monitoring his group ...

GSK will incorporate the findings into messaging that depemokimab patients will adhere to treatment better, ensuring better ...

Sexual health services in the UK will start rolling out a 'world-first' vaccine programme designed to protect people from gonorrhoea in August.

The film tells the story of a family impacted by the disease and shares the importance of checking to make sure that children are vaccinated against all strains.

Patients with asthma who did not persist with biologic treatment had more exacerbations and used more oral corticosteroids, ...

“This is a high-quality study that stands out mainly for its sample size. The results confirm previous findings that people with a history of cold sores have a higher risk of developing Alzheimer’s ...

Microsoft launches Discovery, its new enterprise AI platform from Build 2025, set to accelerate scientific R&D via collaborative AI agents & a graph-knowledge engine for faster innovation.